• Home
  • Victims
    • Vaccine Victims Memorial
    • Gardasil & Silgard
      • G / S Australasia
        • G / S Australia
        • G / S New Zealand
      • G / S Europe
        • G / S Czech Republic
        • G / S Denmark
        • G / S France
        • G / S Germany
        • G / S Ireland
        • G / S Italy
        • G / S Norway
        • G / S Scotland
        • G / S Spain
        • G / S United Kingdom
      • G / S N. America
        • G / S Canada
        • G / S Mexico
        • G / S United States
      • G / S S. America
        • G / S Brazil
        • G/S Colombia
    • Cervarix
      • Cervarix Asia
        • Cervarix India
        • Cervarix Philippines
      • Cervarix Europe
        • Cervarix Czech
        • Cervarix Netherlands
        • Cervarix Scotland
        • Cervarix Slovakia
        • Cervarix Spain
        • Cervarix UK
      • Cervarix N. America
        • Cervarix Mexico
  • Resources
    • HPV Testing Resources
      • Pre-HPV Vaccination
      • Post-HPV Vaccination
    • Medical Professionals
    • Vaccine Injury Attorneys
    • Political Action Groups
    • Vaccine Groups
    • Vaccine Victims Hotline
  • SANE Vax Press Releases
  • Videos
    • Vaccine Safety Videos
    • Vaccine Victim Videos
    • Pharma Videos
  • About
    • About Us
    • Who We Are
    • Press Releases
    • SANE Vax in the News
    • Contact Us

SaneVax, Inc.

The First International HPV Vaccine Information Clearinghouse

  • NEWS
    • Government Agencies
      • African
      • Asian
      • Australasian
      • European
      • North American
      • South American
      • United Nations
      • WHO
    • Pharmaceutical Companies
      • CSL Biotherapies
      • GlaxoSmithKline
      • Inovio Pharmaceuticals
      • Liquidia Technologies
      • Merck & Co.
      • Novartis
      • Pfizer
      • Qiagen
      • Sanofi Aventis
      • Sanofi Pasteur MSD spmsd
      • Wyeth Laboratories
    • Science & Medicine
      • Cancer
      • Clinical Trials
      • Environmental Health
      • Heavy Metal Toxicity
      • HPV Science
      • Influenza
      • Meningitis
      • Pertussis
      • Pharmaceuticals
      • Rotavirus
      • STD’s
      • Vaccine Science
      • Women’s Health
    • Vaccine Adverse Events
    • Vaccine Injury Reporting
      • VAERS
      • VAMPSS
    • Vaccine Litigation
    • Vaccine Marketing
    • Vaccine Politics/People
    • Vaccine Victims
      • Cervarix Injuries
      • DTP/DTaP Injuries
      • Fluvax Injuries
      • Fluzone Injuries
      • Gardasil / Silgard Injuries
      • Menomune Injuries
      • MMR Injuries
      • Polio Vaccine Injuries
      • Synflorix Injuries
      • Yellow Fever Vaccine
    • Vaccines
      • Anthrax
      • Breast Cancer
      • Chicken Pox
      • Cholera
      • Combination Vaccines
      • Diphtheria
      • Hepatitis B
      • HPV
      • Influenza Vaccines
      • Malaria
      • Measles
      • Meningitis Vaccines
      • MRSA
      • Mumps
      • Norovirus
      • Pertussis Vaccines
      • Pneumococcal Disease
      • Polio
      • Rotavirus Vaccines
      • Shingles
      • Smallpox
      • TB
      • Tetanus
      • Typhoid
      • Yellow Fever Vaccine
    • Vaccines and the Media
  • WORLD NEWS
    • Africa
    • Asia
    • Australasia
    • Europe
    • North America
    • South America
  • RESEARCH
    • Cancer Research
    • Cervarix Vaccine
    • Gardasil/Silgard Vaccine
    • Human Pap. Research
    • Immunization Practices
    • Neurology
    • Vaccine Adjuvants
    • Vac. Ingredient Research
    • Vaccine Injuries
    • Vaccine Preservatives
    • Vaccine Related Research
    • Vaccine Safety
  • CITIZENS SPEAK
    • Cervical Cancer Debate
    • HPV Vax
      • Australian Concerns
      • Canadian Concerns
      • Irish Concerns
      • Spain Concerns
      • UK Concerns
      • United States Concerns
You are here: Home / NEWS . . . . . . . . / Science & Medicine / Vaccine Science / Thimerosal Containing Vaccines, Part III – The Convincing Evidence

Thimerosal Containing Vaccines, Part III – The Convincing Evidence

April 5, 2011 By Norma Leave a Comment

By F. Edward Yazbak MD, FAAP

PubMed is a service of the US National Library of Medicine (NLM) of the US National Institutes of Health. According to its main page, “PubMed comprises more than 20 million citations for biomedical literature from MEDLINE, life science journals, and online books. Citations may include links to full-text content from PubMed Central and publisher web sites.”

On March 25, 2011, I accessed PubMed and searched for “thimerosal, vaccine”.

I found 396 citations, the most recent of which (listed as # 1- PMID: 21350943) published on-line February 25, 2011. It was titled “Integrating Experimental (In Vitro and In Vivo) Neurotoxicity Studies of Low-dose Thimerosal Relevant to Vaccines” and authored by Dr. J G Dórea of the Faculty of Health Sciences, Universidade de Brasília, Brazil. This article will be discussed in some detail later.

Readers interested in following this discussion may want to access PubMed at http://www.ncbi.nlm.nih.gov/pubmed/. Alternative searches for “thimerosal vaccine”, “vaccine, thimerosal” or “vaccine thimerosal” will also lead to the same listing.

The 396 titles with authorship and publication details are listed 20 per page on 20 pages. [http://www.ncbi.nlm.nih.gov/pubmed?term=thimerosal%2C%20vaccine]

As of March 25, 2011, there were only three listings for the year: #3 (PMID: 21252391), #6 (PMID: 21185424) and the Dórea paper.

Not all 396 listings deal with the safety vs. neurotoxicity of Thimerosal or of Thimerosal-containing vaccines (TCV), the subject of this three-part series. For example the article listed as # 2 is a report from France of a “case of allergic contact dermatitis three weeks after the H1N1 vaccine, probably involving thimerosal additive.”

The reason for this tedious exercise, probably the first of its kind, is simply to try to determine when peer-reviewed articles related to toxicity /neurotoxicity of Thimerosal-containing- vaccines (TCV) – both pro and con – were first published. The fact that Thimerosal causes allergic reactions such as reported in the publication listed as #2 has been known and reported for decades and is not relevant to this review.

As mentioned in Part 1 and II, the CDC, the FDA and WHO usually start a discussion of the issue of Thimerosal in vaccines by mentioning that the mercury preservative has been used since the 1930s, thus suggesting that it must have been safe and effective.

What those agencies are careful not to ever mention is that the very first article related to Thimerosal in vaccines on PubMed (presently listed as # 396 (PMID: 14249458) was published in October 1964, thirty four years after the 1930s.

[I started practicing pediatrics in 1964 and was just as interested in vaccines then as I am now. I can safely say that I had never heard of the Journal of Pharmaceutical Sciences (Elsevier) where that article was published and that it certainly was not readily available to most practicing US pediatricians at the time.]

The next listed article (presently listed as # 395 (PMID: 14253616) was by the same authors and was published in the following issue of the same journal in November 1964: “Thimerosal as a preservative in biological preparations. 3. Factors affecting the concentration of thimerosal in aqueous solutions and in vaccines stored in rubber-capped bottles.

For some reason, the second part of that apparent 3-part series was not listed.

Those two Birner & Garnet articles were followed by a very long silence probably because no US pediatrician in his right mind, including this writer, could have ever dreamed that FDA-licensed pediatric vaccines on the market contained any more than an infinitesimally small and innocuous amount of the mercury preservative.

Read more….

Related

Filed Under: Vaccine Science, Vaccines Tagged With: mercury, pediatric vaccines, safety

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Follow Us

SaneVax on FacebookSaneVax on TwitterSaneVax on LinkedInSaneVax on YoutubeSaneVax RSS Feed

Help Support SaneVax

Notice: We need your support. This massive research & presentation comes from a team of volunteers. We need your help to keep this critical information available.



SaneVax relies on support from participants like you. We are a 501 (c)(3) non-profit corporation, donations are tax deductible. Help keep this venue available and support the spirit – Thank you!

This Week’s Survivor

Kahlia from New Zealand

Categories

Links

  • Creating an HPV Industry
  • File a VAERS Report
  • Gardasil and Unexplained Deaths
  • HPV Industry Timeline
  • HPV Mechanisms of Action in Women
  • HPV Vaccine Fact Sheet
  • Petition: Rescind HPV Vaccine Approval
  • Presentation to the FDA
  • Supreme Court Arguments

HPV Vaccine VAERS Reports

Description 12/14/2019  TOTAL
Disabled 3,092
Deaths 523
Did Not Recover 13,072
Abnormal Smear 695
Cervical Cancer 186
Infertility 52
Life-threatening 1,001
Emergency Room 15,419
Hospitalized 6,448
Extended Hosp. Stay 304
Serious 9,497
Total Adverse Events 64,270

Access expanded report here.

Related

Subscribe2


 

Log In

Featured Video

People Advocating Vaccine Education P.A.V.E.

People Advocating Vaccine Education P.A.V.E

News

SaneVax News Blog!
News

Videos

Safety • Victims • Pharma
No Genetic Epidemic

Contact

Contact S.A.N.E.Vax
S.A.N.E.VAX log thumbnail

Copyright © 2023 SaneVax, Inc. · Site by TheWebElves.com a div. of KalaRhythms.org · Log in